Drug Profile
Research programme: bradykinin B1 receptor antagonists - Gedeon Richter
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Gedeon Richter
- Class Analgesics; Phenanthridines
- Mechanism of Action Bradykinin B1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for research development in Pain in Hungary
- 02 Aug 2011 A lead compound from this research programme enters clinical development
- 04 Sep 2008 Early research in Pain in Hungary (unspecified route)